• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Role of the tumor marker TAG-72 in head and neck neoplasms].

作者信息

Altissimi G, von Garrel C

机构信息

Universitäts-HNO-Klinik Perugia.

出版信息

HNO. 1990 Oct;38(10):364-6.

PMID:2283330
Abstract

The serum glycoprotein TAG-72 level was determined in 34 patients with chronic laryngitis or ENT malignancy. This marker is in widespread use in cases of gynaecological and gastrointestinal malignancy. TAG-72 levels did not differ significantly either from the levels of healthy subjects or in the post-operative follow-up, so that this indicator appears to be of no clinical value in head and neck oncology.

摘要

相似文献

1
[Role of the tumor marker TAG-72 in head and neck neoplasms].
HNO. 1990 Oct;38(10):364-6.
2
[Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].[应用肿瘤标志物SSC抗原诊断头颈部癌复发]
Laryngorhinootologie. 2000 Apr;79(4):207-12. doi: 10.1055/s-2000-8796.
3
Cyfra 21-1 as a serum tumor marker for follow-up of patients with laryngeal and hypopharyngeal squamous cell carcinoma.细胞角蛋白19片段作为喉和下咽鳞状细胞癌患者随访的血清肿瘤标志物。
Anticancer Res. 2009 Aug;29(8):3421-5.
4
[N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].[N-乙酰神经氨酸（唾液酸）作为头颈癌的肿瘤标志物]
HNO. 1990 Oct;38(10):361-3.
5
[Study of Cyfra 21-1 as a new tumor marker for the diagnosis of epidermoid carcinoma of the head and neck].[细胞角蛋白19片段作为头颈部表皮样癌诊断新肿瘤标志物的研究]
Acta Otorrinolaringol Esp. 1999 Mar;50(2):85-9.
6
[The SCC antigen is not a reliable tumor marker in the ENT area. Value of squamous cell carcinoma antigen in diagnosis and follow-up of squamous epithelial carcinoma in the head-neck area. Results of a retrospective study over 6 years].[鳞状细胞癌抗原在耳鼻喉科领域并非可靠的肿瘤标志物。鳞状细胞癌抗原在头颈部鳞状上皮癌诊断及随访中的价值。一项6年回顾性研究结果]
Laryngorhinootologie. 1998 Mar;77(3):165-7. doi: 10.1055/s-2007-996953.
7
[Squamous cell carcinoma antigen. Current clinical value of a new tumor marker in head and neck cancer; preliminary results of a prospective study after 12 months].[鳞状细胞癌抗原。一种新的肿瘤标志物在头颈癌中的当前临床价值；一项前瞻性研究12个月后的初步结果]
Laryngol Rhinol Otol (Stuttg). 1988 Aug;67(8):420-5.
8
[Relevance of the new tumor marker SCC (squamous cell carcinoma antigen) for the diagnosis and follow-up control of squamous epithelial carcinoma of the head and neck].[新型肿瘤标志物鳞状细胞癌抗原（SCC）对头颈部鳞状上皮癌诊断及随访监测的相关性]
HNO. 1989 Nov;37(11):454-9.
9
The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.铁蛋白、脂质相关唾液酸、癌胚抗原、鳞状细胞癌（SCC）抗原及细胞角蛋白19片段（CYFRA 21-1）水平在头颈部鳞状细胞癌中的意义。
Kulak Burun Bogaz Ihtis Derg. 2004;12(1-2):23-30.
10
Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma.电化学发光免疫分析法对细胞角蛋白19片段（CYFRA 21-1）在头颈部鳞状细胞癌中的分析及临床评估
J Laryngol Otol. 2003 Mar;117(3):190-4. doi: 10.1258/002221503321192485.